Read the original here:
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read the original here:
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Here is the original post:
MDxHealth Shareholder Transparency Declaration
Go here to see the original:
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
Originally posted here:
Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results
Go here to read the rest:
Mesoblast and Oaktree Extend Availability Period of Undrawn Tranches of Financing Facility